Listed

CareDx, Inc.

CDNANasdaqCIK 1217234HealthcareFiscal year ends Dec 31

Reports and events: 255 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

CareDx, Inc., Reports and events
FiledFormWhat it isAccession number
2023-12-2216:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-302096
2023-11-0816:16 ET10-QQuarterly reportPeriod 2023-09-300001217234-23-000226
2023-11-0816:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001217234-23-000224
2023-11-0116:08 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-268195
2023-09-2617:14 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-242583
2023-09-2507:00 ET8-K8.01 Other events0001193125-23-240900
2023-08-0816:18 ET10-QQuarterly reportPeriod 2023-06-300001217234-23-000180
2023-08-0816:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001217234-23-000178
2023-06-2014:52 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001217234-23-000107
2023-05-1016:20 ET10-QQuarterly reportPeriod 2023-03-310001217234-23-000096
2023-05-1016:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001217234-23-000094
2023-04-2816:12 ETDEF 14AProxy statement0001217234-23-000078
2023-04-0307:00 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-23-088888
2023-03-2816:05 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-23-082138
2023-03-1317:51 ET8-K7.01 Regulation FD disclosure0001217234-23-000051
2023-02-2716:28 ET10-KAnnual reportPeriod 2022-12-310001217234-23-000046
2023-02-2716:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001217234-23-000043
2023-01-0907:03 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-004117
2022-12-0608:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-298916
2022-11-2316:02 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-292003
2022-11-0316:26 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001217234-22-000185
2022-11-0316:23 ET10-QQuarterly reportPeriod 2022-09-300001217234-22-000184
2022-09-0716:06 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-239989
2022-09-0116:06 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-236507
2022-08-0417:20 ET10-QQuarterly reportPeriod 2022-06-300001217234-22-000150
2022-08-0416:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001217234-22-000147
2022-06-1713:54 ET8-K5.07 Shareholder vote results0001217234-22-000109
2022-05-2307:30 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-156809
2022-05-0517:13 ET10-QQuarterly reportPeriod 2022-03-310001217234-22-000093
2022-05-0516:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001217234-22-000091
2022-05-0213:15 ETDEF 14AProxy statementPeriod 2022-06-150001217234-22-000084
2022-04-1518:29 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-22-105813
2022-02-2417:07 ET10-KAnnual reportPeriod 2021-12-310001217234-22-000056
2022-02-2416:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001217234-22-000053
2022-01-1008:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001217234-22-000018
2022-01-0508:27 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001217234-22-000004
2021-11-1009:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001217234-21-000245
2021-11-0117:29 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-315657
2021-10-2817:21 ET10-QQuarterly reportPeriod 2021-09-300001217234-21-000235
2021-10-2816:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001217234-21-000233
2021-09-1517:00 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-274069
2021-07-2917:10 ET10-QQuarterly reportPeriod 2021-06-300001217234-21-000190
2021-07-2916:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001217234-21-000188
2021-07-2016:54 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-21-219712
2021-07-0116:20 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-206325
2021-06-2118:55 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-21-193438
2021-06-0316:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001217234-21-000112
2021-05-0517:04 ET10-QQuarterly reportPeriod 2021-03-310001217234-21-000093
2021-05-0516:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001217234-21-000092
2021-04-3011:00 ETDEF 14AProxy statementPeriod 2021-06-150001217234-21-000079

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.